FDA Announces Recall of More than 7000 Bottles of Duloxetine
The US Food and Drug Administration (FDA) has announced a voluntary manufacturer-initiated recall of more than 7srcsrcsrc bottles of duloxetine delayed-release capsules due to unacceptable levels of a potential carcinogen. Duloxetine (Cymbalta) is a serotonin-norepinephrine reuptake inhibitor used to treat major depressive disorder, generalized anxiety disorder…
The US Food and Drug Administration (FDA) has announced a voluntary manufacturer-initiated recall of more than 7srcsrcsrc bottles of duloxetine delayed-release capsules due to unacceptable levels of a potential carcinogen. Duloxetine (Cymbalta) is a serotonin-norepinephrine reuptake inhibitor used to treat major depressive disorder, generalized anxiety disorder…
Read More
About Author
